课题基金 / 基金详情

Defining the Immunomodulatory Role of GPNMB in Triple Negative Breast Cancer

Defining the Immunomodulatory Role of GPNMB in Triple Negative Breast Cancer
定义 GPNMB 在三阴性乳腺癌中的免疫调节作用
批准号:
468016
负责人:
Siegel Peter M
金额:
$72.45万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2027-09-01

项目摘要

项目成果

Siegel Peter M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
BACKGROUND: The body can mount an anti-tumor immune response to eliminate cancer cells. However, cancer cells that are able to evade the immune system can continue to grow and progress to metastatic disease (gain the ability to spread form the primary sit
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying tumor-derived and microenvironmental factors that drive invasive growth of brain metastases
  • 批准号:
    433618
  • 项目类别:
    Operating Grants
  • 资助金额:
    $75.24万
  • 财政年份:
    2020
  • 负责人:
    Siegel Peter M
  • 依托单位:
Deciphering the multi-faceted roles of Afadin in breast cancer metastasis
  • 批准号:
    433637
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.66万
  • 财政年份:
    2020
  • 负责人:
    Siegel Peter M
  • 依托单位:
Optimizing Combination Strategies for GPNMB-expressing Triple Negative Breast Cancers
  • 批准号:
    354630
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2016
  • 负责人:
    Siegel Peter M
  • 依托单位:
Metabolic Adaptations During Breast Cancer Metastasis
  • 批准号:
    343339
  • 项目类别:
    Operating Grants
  • 资助金额:
    $61.26万
  • 财政年份:
    2016
  • 负责人:
    Siegel Peter M
  • 依托单位:
海外基金